4,733
Views
26
CrossRef citations to date
0
Altmetric
Review Article

Echinacea biotechnology: advances, commercialization and future considerations

, , & ORCID Icon
Pages 485-494 | Received 27 Mar 2018, Accepted 14 Jul 2018, Published online: 10 Oct 2018

Figures & data

Figure 1. Structures of Echinacea phytochemicals with established bioactivity. Caffeic acid derivatives are represented by caffeic acid, chlorogenic acid, caftaric acid (left) as well as cichoric and echinacoside (middle). Echinacea alkylamides are represented by the isomers of 2,4,8,10-dodecatetraenoic acid isobutylamide; a diversity of alkylamides in Echinacea are similarly isobutylamides with alkyl chains of variable length and saturation.

Figure 1. Structures of Echinacea phytochemicals with established bioactivity. Caffeic acid derivatives are represented by caffeic acid, chlorogenic acid, caftaric acid (left) as well as cichoric and echinacoside (middle). Echinacea alkylamides are represented by the isomers of 2,4,8,10-dodecatetraenoic acid isobutylamide; a diversity of alkylamides in Echinacea are similarly isobutylamides with alkyl chains of variable length and saturation.

Figure 2. Localization of bioactive compounds in E. purpurea, E. angustifolia, E. pallida, and E. paradoxa. Compounds in bold are present at high concentrations; italics indicate compounds found in trace amount (Sloley et al. Citation2001; Binns et al. Citation2002b; Kabganian et al. Citation2003; Stuart and Wills Citation2003).

Figure 2. Localization of bioactive compounds in E. purpurea, E. angustifolia, E. pallida, and E. paradoxa. Compounds in bold are present at high concentrations; italics indicate compounds found in trace amount (Sloley et al. Citation2001; Binns et al. Citation2002b; Kabganian et al. Citation2003; Stuart and Wills Citation2003).

Table 1. Review of elicitor compounds tested in Echinacea to enhance secondary metabolite content.